BAM
GILD icon

Baring Asset Management’s Gilead Sciences GILD Stock Holding History

Baring Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$1.89M Buy
+23,323
New +$1.78M 0.11% 98
2015
Q1 		– Sell
-157,216
Closed -$14.8M – 146
2014
Q4 		$14.8M Sell
157,216
-17,990
-10% -$1.86M 0.94% 31
2014
Q3 		$18.7M Buy
+175,206
New +$17.2M 1.1% 21

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Baring Asset Management's GILD Position: Q3 2017 in Review

Baring Asset Management opened a new position in Gilead Sciences (GILD) in Q3 2017: 23,323 shares worth $1.89M. The stake represents 0.11% of the portfolio and ranks #98 among its holdings. This is a return to the name: Baring Asset Management previously reported a position in GILD as recently as Q4 2014.

Baring Asset Management first reported a position in GILD in Q3 2014 and has held it in 3 quarters since. The position peaked at $18.7M in Q3 2014. 1,503 funds tracked by Wall St. Rank hold GILD as of Q3 2017.

  • Baring Asset Management held 23,323 shares of Gilead Sciences worth $1.89M as of Q3 2017.
  • Gilead Sciences was a new Baring Asset Management position in Q3 2017.
  • Gilead Sciences made up 0.11% of Baring Asset Management's portfolio in Q3 2017, its #98 holding.
  • Baring Asset Management first reported a position in Gilead Sciences in Q3 2014 and has held it in 3 quarters since.
  • Baring Asset Management's Gilead Sciences position peaked at $18.7M in Q3 2014.
  • 1,503 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2017.

Based on Baring Asset Management's 13F filing for Q3 2017, filed 26 Oct 2017.